Volume 106, Issue 3 p. 512-524
State of the art

Genomic and Metagenomic Approaches for Predictive Surveillance of Emerging Pathogens and Antibiotic Resistance

Kimberley V. Sukhum

Kimberley V. Sukhum

The Edison Family Center for Genome Sciences and Systems Biology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA

Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA

These authors contributed equally to this work.Search for more papers by this author
Luke Diorio-Toth

Luke Diorio-Toth

The Edison Family Center for Genome Sciences and Systems Biology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA

These authors contributed equally to this work.Search for more papers by this author
Gautam Dantas

Corresponding Author

Gautam Dantas

The Edison Family Center for Genome Sciences and Systems Biology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA

Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA

Department of Molecular Microbiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA

Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, USA

Correspondence: Gautam Dantas ([email protected])Search for more papers by this author
First published: 07 June 2019
Citations: 31

Abstract

Antibiotic-resistant organisms (AROs) are a major concern to public health worldwide. While antibiotics have been naturally produced by environmental bacteria for millions of years, modern widespread use of antibiotics has enriched resistance mechanisms in human-impacted bacterial environments. Antibiotic resistance genes (ARGs) continue to emerge and spread rapidly. To combat the global threat of antibiotic resistance, researchers must develop methods to rapidly characterize AROs and ARGs, monitor their spread across space and time, and identify novel ARGs and resistance pathways. We review how high-throughput sequencing-based methods can be combined with classic culture-based assays to characterize, monitor, and track AROs and ARGs. Then, we evaluate genomic and metagenomic methods for identifying ARGs and biosynthetic pathways for novel antibiotics from genomic data sets. Together, these genomic analyses can improve surveillance and prediction of emerging resistance threats and accelerate the development of new antibiotic therapies to combat resistance.

Conflict of Interest

The authors declared no competing interests for this work.